trending Market Intelligence /marketintelligence/en/news-insights/trending/efE4XIYIuItgPpDqcCoGBg2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Aura completes acquisition of 80% stake in German medical cannabis distributor

Blog

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


Aura completes acquisition of 80% stake in German medical cannabis distributor

Canadian cannabis company Aura Health Inc. completed its planned acquisition of an 80% equity interest in Pharmadrug Production GmbH from Anquor Pharmaceuticals UG for €5 million.

Aura inked a definitive deal to acquire the German medical cannabis distributor in late February. German pharmaceutical products supplier Anquor Pharmaceuticals retained a 20% interest in Pharmadrug.

Pharmadrug holds a narcotics license in the EU, which allows it to distribute pharmaceutical products and medical cannabis to German pharmacies and the rest of the eurozone as markets become legalized.

The transaction will help Aura export its own medical cannabis from Israel into the EU. The company also plans to grow the Pharmadrug business through additional supply agreements with other Canadian, European and Israeli licensed producers.